Matthew M. Gosling
2017
In 2017, Matthew M. Gosling earned a total compensation of $2.5M as Senior Vice President and General Counsel at DepoMed, a 26% increase compared to previous year.
Compensation breakdown
| Option Awards | $634,204 |
|---|---|
| Salary | $490,833 |
| Stock Awards | $1,385,330 |
| Other | $6,482 |
| Total | $2,516,849 |
Gosling received $1.4M in stock awards, accounting for 55% of the total pay in 2017.
Gosling also received $634.2K in option awards, $490.8K in salary and $6.5K in other compensation.
Rankings
In 2017, Matthew M. Gosling's compensation ranked 4,388th out of 14,666 executives tracked by ExecPay. In other words, Gosling earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,388 out of 14,666 | 70th |
Division Manufacturing | 1,543 out of 5,772 | 73rd |
Major group Chemicals And Allied Products | 446 out of 2,075 | 79th |
Industry group Drugs | 342 out of 1,731 | 80th |
Industry Pharmaceutical Preparations | 270 out of 1,333 | 80th |
Source: SEC filing on March 27, 2018.
Gosling's colleagues
We found five more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2017.